Campbell & Co Investment Adviser’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Other funds holding BSX
Campbell & Co Investment Adviser's BSX Position: Q2 2026 in Review
Campbell & Co Investment Adviser sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 56,402 shares — an estimated $3.54M sold.
Campbell & Co Investment Adviser first reported a position in BSX in Q4 2013 and held it in 14 quarters. The position peaked at $7.34M in Q4 2025. 770 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- Campbell & Co Investment Adviser reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
- Campbell & Co Investment Adviser sold 56,402 Boston Scientific shares in Q2 2026, an estimated $3.54M.
- Campbell & Co Investment Adviser first reported a position in Boston Scientific in Q4 2013 and held it in 14 quarters.
- Campbell & Co Investment Adviser's Boston Scientific position peaked at $7.34M in Q4 2025.
- 770 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on Campbell & Co Investment Adviser's 13F filing for Q2 2026, filed 3 Aug 2026.